Torrent Pharma to Acquire Controlling Stake in JB Pharma from KKR in INR 25,689 Crore Deal
Torrent Pharmaceuticals has announced plans to acquire a controlling stake in JB Pharma from KKR in an INR 25,689 crore deal, paving the way for a merger that will significantly boost its Indian market position and global expansion strategy.
JB Pharma | 01/07/2025 | By Mrinmoy Dey | 180
JB Pharma Releases its Third Sustainability Report FY24
JB Pharma’s third sustainability report highlights the company’s achievements in reducing its environmental impact and improving resource efficiency.
JB Pharma | 22/10/2024 | By Aishwarya | 475
JB Pharma to acquire the entire Razel (Rosuvastatin) franchise for Rs. 314 crores
The acquisition marks JB Pharma’s entry into the ‘Statin’ segment which is the largest group in the cardiac therapy. Razel ranks among the top 10 brands in the Rosuvastatin molecule category in the country <br />
JB Pharma | 15/12/2022 | By Sudeep Soparkar | 476
JB Pharma commits to ESG in its maiden Sustainability Report
The sustainability report is for the year FY 2021 – 2022
JB Pharma | 17/10/2022 | By Sudeep Soparkar | 466
JB Pharma initiates #Heart2HeartChallengeIndia
Aims to spread awareness about heart health amongst the masses
JB Pharma | 22/09/2022 | By Sudeep Soparkar | 669
IQVIA Market Reflection Report - JB Pharma
IQVIA Market Reflection Report pins JB Pharma as the fastest growing Pharma Company with a growth rate of over 20% for the month of August 2022
JB Pharma | 22/09/2022 | By Sudeep Soparkar | 828
JB Pharma acquires four paediatric brands from Dr Reddy's Laboratories
The total covered market size of four brands – Z&D, Pedicloryl, Pecef and Ezinapi combined is Rs 1800 crores
JB Pharma | 01/07/2022 | By Sudeep Soparkar | 433
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy